Home › Funds › Two Sigma Investments › ORIC
Two Sigma Investments position in ORIC
ORIC PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)603.66K sh
Reported value held$6.54M
Portfolio Weight0.01%
First reportedQ1 2022
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2022 | 319.36K | $1.71M | New |
| Q2 2022 | 235.34K | $1.05M | Reduce |
| Q3 2022 | 174.06K | $557.00K | Reduce |
| Q4 2022 | 46.57K | $274.29K | Reduce |
| Q1 2023 | 43.42K | $247.49K | Reduce |
| Q2 2023 | 106.61K | $827.33K | Add |
| Q3 2023 | 31.11K | $188.24K | Reduce |
| Q4 2023 | 105.01K | $966.09K | Add |
| Q1 2024 | 109.01K | $1.50M | Add |
| Q2 2024 | 262.51K | $1.86M | Add |
| Q3 2024 | 184.07K | $1.89M | Reduce |
| Q4 2024 | 139.68K | $1.13M | Reduce |
| Q1 2025 | 76.99K | $429.60K | Reduce |
| Q2 2026 | 603.66K | $6.54M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ORIC
- BlackRock Inc 6.82M sh · $73.90M · Q2 2026
- Viking Global Investors 5.13M sh · $55.52M · Q2 2026
- Alkeon Capital Management 3.74M sh · $40.49M · Q2 2026
- Vanguard Group 4.54M sh · $37.15M · Q4 2025
- Fidelity Management & Research (FMR) 2.64M sh · $28.54M · Q2 2026
- Citadel Advisors 2.62M sh · $28.39M · Q2 2026
- Goldman Sachs Group 2.45M sh · $26.55M · Q2 2026
- Geode Capital Management 2.09M sh · $22.64M · Q2 2026
- Franklin Resources 1.80M sh · $19.47M · Q2 2026
- Morgan Stanley 1.79M sh · $19.43M · Q2 2026
- D. E. Shaw & Co 1.58M sh · $17.11M · Q2 2026
- Bank of America Corp 1.08M sh · $11.68M · Q2 2026